Long-dated call buying and $150 put selling suggest institutions are positioned for upside in Nebius into 2027, a stronger bullish read than Marvell. Unusual Whales data show over $25 million in two call blocks, though one may be a roll, and over $12 million in $150 puts sold. The 19% two-day bounce lacked confirming options inflows, so Nebius could retest $170 before Nov. 10 earnings, with a roughly 18% implied move. x.com 

Options flow on Marvell is very bullish, with sellers underwriting its downside at every level from $300 to $130. About $11 million of puts were sold before noon against $3 million of calls bought, including deep in-the-money 2028 $300 puts, effectively a synthetic long with the stock near $215, plus $200 and $270 calls into earnings. The stock is down 43% from its high. It is one morning of flow; sellers can be hedged, and short puts work until a gap. x.com 

Marvell's jump to $290 on its S&P 500 inclusion is a forced institutional pump that looks like a short-term top. Once index funds finish their mechanical rebalancing, that artificial demand dries up and often triggers a sharp sell-the-news flush. The large gap below on the chart acts as a magnet, pointing to a healthy pullback toward the $214-220 zone, where $214 lines up with the 0.786 Fibonacci level. x.com 

Marvell can easily reach $250 this year after beating and raising guidance. Per @Noamneo_, it posted record Q1 revenue of $2.42B and crushed EPS estimates, and data center is now 76% of the business and still exploding. x.com  x.com 

Marvell's S&P 500 inclusion should force passive buying from every index-tracking fund once it takes effect, with the action starting Monday. A brief pullback is likely before the next leg up toward a $1 trillion market cap. x.com  x.com 

Marvell's run looks like distribution, not accumulation: it doubled in four months on decelerating earnings, spiked on a CEO's compliment and printed its heaviest volume at the top. After Jensen Huang called it the next trillion-dollar company at Computex, it jumped 32% in a day, capping a 105% gain in 18 weeks on record volume of 441 million shares, while EPS growth slowed four straight quarters from 158% to 29%. A 40% collapse from the peak in five weeks followed, the mark of a climax run. … Show more

Marvell's $70-90 billion FY31 revenue target looks credible: COO Chris Koopmans said key foundry, substrate and packaging suppliers get five-year forecasts and had already seen it before investor day. A $500 price target still looks too aggressive for now; Marvell must show it can grow its networking and photonics segment to deserve a safe price increase. x.com  x.com 

A Lumentum deal would put Marvell in a much better competitive position, making its shares an obvious buy here, especially for existing Lumentum shareholders. If the deal breaks, Marvell shares would jump sharply; a moderate premium could mean near-term weakness or sideways trading but would be a great long-term deal. A big premium could push shares down further, though much of that risk is already priced in. x.com  x.com 

Marvell's ambitious long-range outlook is encouraging about hyperscaler and AI-lab spending plans, but hitting it depends on AI revenue and token consumption soaring through decade's end. Even if its FY28 estimates rise again, Marvell trades at a healthy premium to Nvidia and Broadcom, especially on a GAAP basis, and those two are growing fast too. x.com 

Marvell still has upside to run, and AMD's buying at the lows signals it. AMD bought $6.5 million of Marvell stock at $99, the same week the semiconductor rally began, and Marvell now trades at $176. When companies buy each other's stock at exact lows, it isn't luck. x.com  x.com